Rilas Technologies

Executive Summary

Rilas Technologies is a contract research organization (CRO) specializing in analytical chemistry and purification services for biotech and pharmaceutical companies. Founded in 2009 and based in Woburn, Massachusetts, the company supports drug development from discovery through pre-clinical stages, focusing on small molecules, peptides, proteins, and antibodies. Its offerings include method development, preparative chromatography, and LC-MS analysis, positioning it as an extension of clients' R&D teams. As a private, pre-clinical stage CRO, Rilas benefits from steady demand for outsourced analytical services, though it operates in a competitive landscape with larger players. The company's niche expertise and experienced team provide a foundation for stable growth.

Upcoming Catalysts (preview)

• Q3 2026Expansion of service offerings to include large molecule analytics40% success